These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18973685)

  • 21. Anti-amyloidogenic property of human gastrokine 1.
    Altieri F; Di Stadio CS; Severino V; Sandomenico A; Minopoli G; Miselli G; Di Maro A; Ruvo M; Chambery A; Quagliariello V; Masullo M; Rippa E; Arcari P
    Biochimie; 2014 Nov; 106():91-100. PubMed ID: 25139219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational solution studies of the SDS micelle-bound 11-28 fragment of two Alzheimer's beta-amyloid variants (E22K and A21G) using CD, NMR, and MD techniques.
    Rodziewicz-Motowidło S; Juszczyk P; Kołodziejczyk AS; Sikorska E; Skwierawska A; Oleszczuk M; Grzonka Z
    Biopolymers; 2007 Sep; 87(1):23-39. PubMed ID: 17534931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The recombinant amyloid-beta peptide Abeta1-42 aggregates faster and is more neurotoxic than synthetic Abeta1-42.
    Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2010 Feb; 396(1):9-18. PubMed ID: 20026079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and purification of 15N- and 13C-isotope labeled 40-residue human Alzheimer's β-amyloid peptide for NMR-based structural analysis.
    Long F; Cho W; Ishii Y
    Protein Expr Purif; 2011 Sep; 79(1):16-24. PubMed ID: 21640828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and mechanistic studies of an antiamyloidogenic self-assembled cyclic D,L-α-peptide architecture.
    Richman M; Wilk S; Chemerovski M; Wärmländer SK; Wahlström A; Gräslund A; Rahimipour S
    J Am Chem Soc; 2013 Mar; 135(9):3474-84. PubMed ID: 23360549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
    Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
    Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A strategy for designing a peptide probe for detection of β-amyloid oligomers.
    Hu Y; Su B; Kim CS; Hernandez M; Rostagno A; Ghiso J; Kim JR
    Chembiochem; 2010 Nov; 11(17):2409-18. PubMed ID: 21031399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease.
    Itkin A; Dupres V; Dufrêne YF; Bechinger B; Ruysschaert JM; Raussens V
    PLoS One; 2011 Mar; 6(3):e18250. PubMed ID: 21464905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large-scale production of soluble recombinant amyloid-β peptide 1-42 using cold-inducible expression system.
    Kim EK; Moon JC; Lee JM; Jeong MS; Oh C; Ahn SM; Yoo YJ; Jang HH
    Protein Expr Purif; 2012 Nov; 86(1):53-7. PubMed ID: 22982229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique physicochemical profile of beta-amyloid peptide variant Abeta1-40E22G protofibrils: conceivable neuropathogen in arctic mutant carriers.
    Päiviö A; Jarvet J; Gräslund A; Lannfelt L; Westlind-Danielsson A
    J Mol Biol; 2004 May; 339(1):145-59. PubMed ID: 15123427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Osaka FAD mutation E22Δ leads to the formation of a previously unknown type of amyloid β fibrils and modulates Aβ neurotoxicity.
    Ovchinnikova OY; Finder VH; Vodopivec I; Nitsch RM; Glockshuber R
    J Mol Biol; 2011 May; 408(4):780-91. PubMed ID: 21402079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Arctic amyloid-β precursor protein (AβPP) mutation results in distinct plaques and accumulation of N- and C-truncated Aβ.
    Philipson O; Lord A; Lalowski M; Soliymani R; Baumann M; Thyberg J; Bogdanovic N; Olofsson T; Tjernberg LO; Ingelsson M; Lannfelt L; Kalimo H; Nilsson LN
    Neurobiol Aging; 2012 May; 33(5):1010.e1-13. PubMed ID: 22118948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloidogenicity and Cytotoxicity of a Recombinant C-Terminal His
    Jia L; Wang W; Sang J; Wei W; Zhao W; Lu F; Liu F
    ACS Chem Neurosci; 2019 Mar; 10(3):1251-1262. PubMed ID: 30537813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-β Variants and Structural Analysis by Solution NMR Spectroscopy.
    Dammers C; Gremer L; Neudecker P; Demuth HU; Schwarten M; Willbold D
    PLoS One; 2015; 10(10):e0139710. PubMed ID: 26436664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A peptide probe for detection of various beta-amyloid oligomers.
    Hu Y; Su B; Zheng H; Kim JR
    Mol Biosyst; 2012 Oct; 8(10):2741-52. PubMed ID: 22832997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic amino acid substitution of Tyr10 in Aβ peptide sequence yields a dominant negative variant in amyloidogenesis.
    Mazargui H; Lévêque C; Bartnik D; Fantini J; Gouget T; Melone MA; Funke SA; Willbold D; Perrone L
    Aging Cell; 2012 Jun; 11(3):530-41. PubMed ID: 22385841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A beta-amino acid modified heptapeptide containing a designed recognition element disrupts fibrillization of the amyloid beta-peptide.
    Castelletto V; Hamley IW; Lim T; De Tullio MB; Castaño EM
    J Pept Sci; 2010 Sep; 16(9):443-50. PubMed ID: 20648477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.